Stifel on Elanco Animal Health (ELAN): 'Zenrelia Approved - What We Currently Know'
Tweet Send to a Friend
Stifel analyst Jonathan Block reiterated a Buy rating and $20.00 price target on Elanco Animal Health (NYSE: ELAN).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
